+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetic Ulcers Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851672
  • Report
  • January 2019
  • Region: Global
  • 382 pages
  • Transparency Market Research
1 of 2

Global Diabetic Ulcers Treatment Market: Overview

This report analyzes the current and future scenario of the global diabetic ulcers treatment market. Rise in the prevalence of diabetic foot ulcers, surge in adoption of technologically advanced wound care products, increase in geriatric population, and rise in patient awareness and health care expenditure are key factors that are projected to drive the global market during the forecast period. 

The global diabetic ulcers treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on ulcer type, treatment type, grade, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global diabetic ulcers treatment market. 

Global Diabetic Ulcers Treatment Market: Key Segments

The global diabetic ulcers treatment market has been segmented based on ulcer type, treatment type, grade, end-user, and region. In terms of ulcer type, the global market has been classified into foot ulcer, mouth ulcer, skin ulcer, corneal ulcer, and others. The foot ulcer segment has been further sub-segmented into neuropathic ulcer and ischemic ulcer and neuro-ischemic ulcer. Based on treatment type, the diabetic ulcers treatment market has been categorized into wound care dressings, wound care devices, active therapies, and others. The wound care dressings segment has been further sub-segmented into antimicrobial dressings, foam dressings, film dressings, alginate dressings, hydrogel dressings, and others. The wound care devices segment has been further split into negative pressure wound therapy, ultrasound therapy, and HBOT and electromagnetic therapy. The active therapies segment has been further sub-segmented into skin grafts and substitutes, growth factors, and hemostatic agents and sealants. The others segment has been further bifurcated into pressure relief devices, traditional wound care products, and others. Based on grade, the market has been classified into grade 1, grade 2, grade 3, grade 4, and grade 5. In terms of end-user, the market has been split into hospital inpatient settings, hospital outpatient settings, community health centers, and home health care. Based on region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these segments have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. 

Global Diabetic Ulcers Treatment Market: Regional Outlook

In terms of region, the global diabetic ulcers treatment market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, Russia and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, and rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players in the global diabetic ulcers treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Smith & Nephew plc, Integra Life Sciences Corporation, Hill-Rom Holdings, Inc., MölnlyckeHealth Care AB, Essity Aktiebolag, Cardinal Health, 3M Healthcare, B. Braun Melsungen AG, AcelityL.P., Inc., and ConvaTec, Inc. 

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Diabetic Ulcers Treatment Market

4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diabetic Ulcers Treatment Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Treatment Cost Analysis (2017)
5.2. Key Vendor and Distributor Analysis
5.3. Overview of Global Diabetic Ulcers Market and Forecast, 2018-2026
5.4. Epidemiology of Diabetic Ulcers (Foot Ulcer, Corneal Ulcer, Skin Ulcer, Mouth Ulcer, and Others)
5.5. Regulatory Scenario of Diabetic Ulcers (Foot Ulcer, Corneal Ulcer, Skin Ulcer, Mouth Ulcer, and Others)
5.6. Key Treatment of Diabetic Ulcers
5.7. Key Developments in Diabetic Ulcers Treatment

6. Global Diabetic Ulcers Treatment Market Analysis and Forecast, by Ulcer Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Diabetic Ulcers Treatment Market Value Forecast, by Ulcer Type, 2016-2026
6.3.1. Foot Ulcer
6.3.1.1. Neuropathic Ulcer
6.3.1.2. Ischemic Ulcer and Neuro-Ischemic Ulcer
6.3.2. Mouth Ulcer
6.3.3. Skin Ulcer
6.3.4. Corneal Ulcer
6.3.5. Others

7. Global Diabetic Ulcers Treatment Market Analysis and Forecast, by Treatment Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Diabetic Ulcers Treatment Market Value Forecast, by Treatment Type, 2016-2026
7.3.1. Wound Care Dressings
7.3.1.1. Antimicrobial Dressings
7.3.1.2. Foam Dressings
7.3.1.3. Film Dressings
7.3.1.4. Alginate Dressings
7.3.1.5. Hydrogel Dressings
7.3.1.6. Other Dressings
7.3.2. Wound Care Devices
7.3.2.1. NPWT
7.3.2.2. Ultrasound Therapy
7.3.2.3. HBOT and Electromagnetic Therapy
7.3.3. Active Therapies
7.3.3.1. Skin Grafts & Substitutes
7.3.3.2. Growth Factors
7.3.3.3. Hemostatic Agents and Sealants
7.3.4. Others
7.3.4.1. Pressure Relief Devices
7.3.4.2. Traditional Wound Care Products
7.3.4.3. Others
7.4. Global Diabetic Ulcers Treatment Market Attractiveness, by Treatment Type

8. Global Diabetic Ulcers Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Diabetic Ulcers Treatment Market Value Forecast, by End-user, 2016-2026
8.3.1. Hospital Inpatient Settings
8.3.2. Hospital Outpatient Settings
8.3.3. Community Health Centers
8.3.4. Home Health Care
8.4. Global Diabetic Ulcers Treatment Market Attractiveness, by End-user

9. Global Diabetic Ulcers Treatment Market Analysis and Forecast, by Grade
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Global Diabetic Ulcers Treatment Market Value Forecast, by Grade, 2016-2026
9.3.1. Grade 1
9.3.2. Grade 2
9.3.3. Grade 3
9.3.4. Grade 4
9.3.5. Grade 5
9.4. Global Diabetic Ulcers Treatment Market Attractiveness, by Grade

10. Global Diabetic Ulcers Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Diabetic Ulcers Treatment Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Diabetic Ulcers Treatment Market Attractiveness, by Country/Region

11. North America Diabetic Ulcers Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Diabetic Ulcers Treatment Market Value Forecast, by Ulcer Type, 2016-2026
11.2.1. Foot Ulcer
11.2.1.1. Neuropathic Ulcer
11.2.1.2. Ischemic Ulcer and Neuro-Ischemic Ulcer
11.2.2. Mouth Ulcer
11.2.3. Skin Ulcer
11.2.4. Corneal Ulcer
11.2.5. Others
11.3. North America Diabetic Ulcers Treatment Market Value Forecast, by Treatment Type, 2016-2026
11.3.1. Wound Care Dressings
11.3.1.1. Antimicrobial Dressings
11.3.1.2. Foam Dressings
11.3.1.3. Film Dressings
11.3.1.4. Alginate Dressings
11.3.1.5. Hydrogel Dressings
11.3.1.6. Other Dressings
11.3.2. Wound Care Devices
11.3.2.1. NPWT
11.3.2.2. Ultrasound Therapy
11.3.2.3. HBOT and Electromagnetic Therapy
11.3.3. Active Therapies
11.3.3.1. Skin Grafts & Substitutes
11.3.3.2. Growth Factors
11.3.3.3. Hemostatic Agents and Sealants
11.3.4. Others
11.3.4.1. Pressure Relief Devices
11.3.4.2. Traditional Wound Care Products
11.3.4.3. Others
11.4. North America Diabetic Ulcers Treatment Market Value Forecast, by End-user, 2016-2026
11.4.1. Hospital Inpatient Settings
11.4.2. Hospital Outpatient Settings
11.4.3. Community Health Centers
11.4.4. Home Health Care
11.5. North America Diabetic Ulcers Treatment Market Value Forecast, by Grade, 2016-2026
11.5.1. Grade 1
11.5.2. Grade 2
11.5.3. Grade 3
11.5.4. Grade 4
11.5.5. Grade 5
11.6. North America Diabetic Ulcers Treatment Market Value Forecast, by Country, 2016-2026
11.6.1. U.S.
11.6.2. Canada
11.7. North America Diabetic Ulcers Treatment Market Attractiveness Analysis
11.7.1. By Ulcer Type
11.7.2. By Treatment Type
11.7.3. By End-user
11.7.4. By Grade
11.7.5. By Country/Sub-region

12. Europe Diabetic Ulcer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Diabetic Ulcers Treatment Market Value Forecast, by Ulcer Type, 2016-2026
12.2.1. Foot Ulcer
12.2.1.1. Neuropathic Ulcer
12.2.1.2. Ischemic Ulcers and Neuro-Ischemic Ulcer
12.2.2. Mouth Ulcer
12.2.3. Skin Ulcer
12.2.4. Corneal Ulcer
12.2.5. Others
12.3. Europe Diabetic Ulcers Treatment Market Value Forecast, by Treatment Type, 2016-2026
12.3.1. Wound Care Dressings
12.3.1.1. Antimicrobial Dressings
12.3.1.2. Foam Dressings
12.3.1.3. Film Dressings
12.3.1.4. Alginate Dressings
12.3.1.5. Hydrogel Dressings
12.3.1.6. Other Dressings
12.3.2. Wound Care Devices
12.3.2.1. NPWT
12.3.2.2. Ultrasound Therapy
12.3.2.3. HBOT and Electromagnetic Therapy
12.3.3. Active Therapies
12.3.3.1. Skin Grafts & Substitutes
12.3.3.2. Growth Factors
12.3.3.3. Hemostatic Agents and Sealants
12.3.4. Others
12.3.4.1. Pressure Relief Devices
12.3.4.2. Traditional Wound Care Products
12.3.4.3. Others
12.4. Europe Diabetic Ulcers Treatment Market Value Forecast, by End-user, 2016-2026
12.4.1. Hospital Inpatient Settings
12.4.2. Hospital Outpatient Settings
12.4.3. Community Health Centers
12.4.4. Home Health Care
12.5. Europe Diabetic Ulcers Treatment Market Value Forecast, by Grade, 2016-2026
12.5.1. Grade 1
12.5.2. Grade 2
12.5.3. Grade 3
12.5.4. Grade 4
12.5.5. Grade 5
12.6. Europe Diabetic Ulcers Treatment Market Value Forecast, by Country/Sub-region, 2016-2026
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Russia
12.6.7. Rest of Europe
12.7. Europe Diabetic Ulcers Treatment Market Attractiveness Analysis
12.7.1. By Ulcer Type
12.7.2. By Treatment Type
12.7.3. By End-user
12.7.4. By Grade
12.7.5. By Country/Sub-region

13. Asia Pacific Diabetic Ulcers Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Diabetic Ulcers Treatment Market Value Forecast, by Ulcer Type, 2016-2026
13.2.1. Foot Ulcer
13.2.1.1. Neuropathic Ulcer
13.2.1.2. Ischemic Ulcers and Neuro-Ischemic Ulcer
13.2.2. Mouth Ulcer
13.2.3. Skin Ulcer
13.2.4. Corneal Ulcer
13.2.5. Others
13.3. Asia Pacific Diabetic Ulcers Treatment Market Value Forecast, by Treatment Type, 2016-2026
13.3.1. Wound Care Dressings
13.3.1.1. Antimicrobial Dressings
13.3.1.2. Foam Dressings
13.3.1.3. Film Dressings
13.3.1.4. Alginate Dressings
13.3.1.5. Hydrogel Dressings
13.3.1.6. Other Dressings
13.3.2. Wound Care Devices
13.3.2.1. NPWT
13.3.2.2. Ultrasound Therapy
13.3.2.3. HBOT and Electromagnetic Therapy
13.3.3. Active Therapies
13.3.3.1. Skin Grafts & Substitutes
13.3.3.2. Growth Factors
13.3.3.3. Hemostatic Agents and Sealants
13.3.4. Others
13.3.4.1. Pressure Relief Devices
13.3.4.2. Traditional Wound Care Products
13.3.4.3. Others
13.4. Asia Pacific Diabetic Ulcers Treatment Market Value Forecast, by End-user, 2016-2026
13.4.1. Hospital Inpatient Settings
13.4.2. Hospital Outpatient Settings
13.4.3. Community Health Centers
13.4.4. Home Health Care
13.5. Asia Pacific Diabetic Ulcers Treatment Market Value Forecast, by Grade, 2016-2026
13.5.1. Grade 1
13.5.2. Grade 2
13.5.3. Grade 3
13.5.4. Grade 4
13.5.5. Grade 5
13.6. Asia Pacific Diabetic Ulcers Treatment Market Value Forecast, by Country/Sub-region, 2016-2026
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Diabetic Ulcers Treatment Market Attractiveness Analysis
13.7.1. By Ulcer Type
13.7.2. By Treatment Type
13.7.3. By End-user
13.7.4. By Grade
13.7.5. By Country/Sub-region

14. Latin America Diabetic Ulcers Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Diabetic Ulcers Treatment Market Value Forecast, by Ulcer Type, 2016-2026
14.2.1. Foot Ulcer
14.2.1.1. Neuropathic Ulcer
14.2.1.2. Ischemic Ulcers and Neuro-Ischemic Ulcer
14.2.2. Mouth Ulcer
14.2.3. Skin Ulcer
14.2.4. Corneal Ulcer
14.2.5. Others
14.3. Latin America Diabetic Ulcers Treatment Market Value Forecast, by Treatment Type, 2016-2026
14.3.1. Wound Care Dressings
14.3.1.1. Antimicrobial Dressings
14.3.1.2. Foam Dressings
14.3.1.3. Film Dressings
14.3.1.4. Alginate Dressings
14.3.1.5. Hydrogel Dressings
14.3.1.6. Other Dressings
14.3.2. Wound Care Devices
14.3.2.1. NPWT
14.3.2.2. Ultrasound Therapy
14.3.2.3. HBOT and Electromagnetic Therapy
14.3.3. Active Therapies
14.3.3.1. Skin Grafts & Substitutes
14.3.3.2. Growth Factors
14.3.3.3. Hemostatic Agents and Sealants
14.3.4. Others
14.3.4.1. Pressure Relief Devices
14.3.4.2. Traditional Wound Care Products
14.3.4.3. Others
14.4. Latin America Diabetic Ulcers Treatment Market Value Forecast, by End-user, 2016-2026
14.4.1. Hospital Inpatient Settings
14.4.2. Hospital Outpatient Settings
14.4.3. Community Health Centers
14.4.4. Home Health Care
14.5. Latin America Diabetic Ulcers Treatment Market Value Forecast, by Grade, 2016-2026
14.5.1. Grade 1
14.5.2. Grade 2
14.5.3. Grade 3
14.5.4. Grade 4
14.5.5. Grade 5
14.6. Latin America Diabetic Ulcers Treatment Market Value Forecast, by Country/Sub-region, 2016-2026
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Diabetic Ulcers Treatment Market Attractiveness Analysis
14.7.1. By Ulcer Type
14.7.2. By Treatment Type
14.7.3. By End-user
14.7.4. By Grade
14.7.5. By Country/Sub-region

15. Middle East & Africa Diabetic Ulcers Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Diabetic Ulcers Treatment Market Value Forecast, by Ulcer Type, 2016-2026
15.2.1. Foot Ulcer
15.2.1.1. Neuropathic Ulcer
15.2.1.2. Ischemic Ulcers and Neuro-Ischemic Ulcer
15.2.2. Mouth Ulcer
15.2.3. Skin Ulcer
15.2.4. Corneal Ulcer
15.2.5. Others
15.3. Market Value Forecast, by Treatment Type, 2016-2026
15.3.1. Wound Care Dressings
15.3.1.1. Antimicrobial Dressings
15.3.1.2. Foam Dressings
15.3.1.3. Film Dressings
15.3.1.4. Alginate Dressings
15.3.1.5. Hydrogel Dressings
15.3.1.6. Other Dressings
15.3.2. Wound Care Devices
15.3.2.1. NPWT
15.3.2.2. Ultrasound Therapy
15.3.2.3. HBOT and Electromagnetic Therapy
15.3.3. Active Therapies
15.3.3.1. Skin Grafts & Substitutes
15.3.3.2. Growth Factors
15.3.3.3. Hemostatic Agents and Sealants
15.3.4. Others
15.3.4.1. Pressure Relief Devices
15.3.4.2. Traditional Wound Care Products
15.3.4.3. Others
15.4. Middle East & Africa Diabetic Ulcers Treatment Market Value Forecast, by End-user, 2016-2026
15.4.1. Hospital Inpatient Settings
15.4.2. Hospital Outpatient Settings
15.4.3. Community Health Centers
15.4.4. Home Health Care
15.5. Middle East & Africa Diabetic Ulcers Treatment Market Value Forecast, by Grade, 2016-2026
15.5.1. Grade 1
15.5.2. Grade 2
15.5.3. Grade 3
15.5.4. Grade 4
15.5.5. Grade 5
15.6. Middle East & Africa Diabetic Ulcers Treatment Market Value Forecast, by Country/Sub-region, 2016-2026
15.6.1. GCC
15.6.2. South Africa
15.6.3. Israel
15.6.4. Rest of Middle East & Africa
15.7. Middle East & Africa Diabetic Ulcers Treatment Market Attractiveness Analysis
15.7.1. By Ulcer Type
15.7.2. By Treatment Type
15.7.3. By End-user
15.7.4. By Grade
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2017)
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1. Smith & Nephew plc
16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.1.2. Financial Overview
16.4.1.3. Product Portfolio
16.4.1.4. SWOT Analysis
16.4.1.5. Strategic Overview
16.4.2. Integra LifeSciencesCorporation
16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.2.2. Financial Overview
16.4.2.3. Product Portfolio
16.4.2.4. SWOT Analysis
16.4.2.5. Strategic Overview
16.4.3. Hill-Rom Holdings, Inc.
16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.3.2. Financial Overview
16.4.3.3. Product Portfolio
16.4.3.4. SWOT Analysis
16.4.3.5. Strategic Overview
16.4.4. MölnlyckeHealth Care AB
16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.4.2. Financial Overview
16.4.4.3. Product Portfolio
16.4.4.4. SWOT Analysis
16.4.4.5. Strategic Overview
16.4.5. Essity Aktiebolag
16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.5.2. Financial Overview
16.4.5.3. Product Portfolio
16.4.5.4. SWOT Analysis
16.4.5.5. Strategic Overview
16.4.6. Cardinal Health
16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.6.2. Financial Overview
16.4.6.3. Product Portfolio
16.4.6.4. SWOT Analysis
16.4.6.5. Strategic Overview
16.4.7. 3M Healthcare
16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.7.2. Financial Overview
16.4.7.3. Product Portfolio
16.4.7.4. SWOT Analysis
16.4.7.5. Strategic Overview
16.4.8. B. Braun Melsungen AG
16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.8.2. Financial Overview
16.4.8.3. Product Portfolio
16.4.8.4. SWOT Analysis
16.4.8.5. Strategic Overview
16.4.9. AcelityL.P., Inc.
16.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.9.2. Financial Overview
16.4.9.3. Product Portfolio
16.4.9.4. SWOT Analysis
16.4.9.5. Strategic Overview
16.4.10. ConvaTec, Inc.
16.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.10.2. Financial Overview
16.4.10.3. Product Portfolio
16.4.10.4. SWOT Analysis
16.4.10.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll